Abstract Cardiovascular implantable electronic devices (CIEDs) provide lifesaving support and an improved quality of life to millions of patients. With these patients presenting for elective, urgent, and emergent surgeries, anesthesiologists and other perioperative physicians should become familiar with the various types of devices as well as their perioperative management. The literature regarding the perioperative management of CIEDs has been confusing and at times contradictory; however, more recent publications have offered a thoughtful and educational approach to the perioperative management of CIEDs. This article will summarize some of the current concepts of perioperative management of CIEDs.
Introduction
The rapidly expanding technology of cardiovascular implantable electronic devices (CIEDs) as well as their widespread use not only for bradyarrhythmia and tachyarrhythmia management, but also for congestive heart failure management, has ushered in an era where patients who experience long-term benefit from such therapy are presenting for both cardiac and noncardiac surgery [1, 2] . With approximately one million patients worldwide receiving a pacemaker or implantable cardioverter defibrillator (ICD) every year, patients with CIEDs are a growing population in the perioperative arena [3 • ]. As ''internists of the operating room'' who routinely manage complex, life-threatening medical illnesses such as diabetes, anesthesiologists are increasingly asked to address the perioperative management of patients with CIEDs. Management of CIEDs in the perioperative period may be complicated [4, 5] . Until recently, there was little guidance, confusing literature, and frank misinformation regarding the perioperative management of CIEDs.
The July 2011 Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with CIEDs has sought to inform perioperative physicians and encourage responsible communication between the CIED team that typically manages patients with devices and the perioperative team [6 •• ] . The HRS/ASA Expert Consensus Statement on the perioperative management of CIEDs has also been endorsed by the AHA, ACC, and STS. Due to its relatively recent publication in the leading electrophysiology journal, most anesthesiologists are not familiar with the document or its details. Additionally, due to the technical complexity of CIEDs, lack of standardization of technology, and the dearth of education regarding these devices in clinical training programs, many advanced perioperative physicians find it challenging to learn about the perioperative management of CIEDs.
Perioperative Considerations

Preoperative Assessment
Basic terminology/codes for pacemakers and ICDs are reviewed in many manuscripts and texts [7] . Respectively, the pacemaker code represents the chamber paced, the chamber sensed, the response to sensing, and the rate responsive mode.
The need for two-way communication between patient's CIED team that usually takes care of the device programming and function and the operative team was emphasized by the Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement published in July 2011. The most effective means of caring for the patient with a CIED will occur when the CIED team that usually manages the patient's device is given the necessary details of the operative procedure in order to create an individualized, perioperative prescription. The information that should be exchanged is summarized in Tables 1 and 2 .
Electromagnetic Interference
Electromagnetic interference (EMI) in the preoperative settings can interfere with the functioning of both pacemakers and ICDs, presenting a challenge to the management of these devices [8] [9] [10] . Although there are several potential sources of EMI, the major source is monopolar electrocautery, particularly if the source of EMI is within 6 inches (15 cm) of the generator. Bipolar electrocautery is usually not a concern, as the electrical current field is small, limited to the two poles at the end of the stylus [11] .
Monopolar electrocautery is the most frequently used type of electrocautery because it has both cutting as well as coagulation capabilities. Modern CIEDs have evolved to produce better shielding from EMI. Contrary to common belief, shielding from EMI does not reduce the potential to induce a ''reset'' mode (which is discussed later), but rather shielding reduces the potential to induce oversensing in the CIED. Oversensing in a pacemaker means the pacemaker ''sees'' the EMI generated artifacts as intrinsic cardiac electrical activity and, therefore, does not initiate a paced rhythm. Such failure to initiate a paced rhythm (inhibition of the pacemaker) can compromise hemodynamics in a pacemaker-dependent patient. If oversensing occurs in an ICD, EMI may be misinterpreted by the ICD as a malignant tachyarrhythmia, which may cause the patient to receive an inappropriate shock [12] . EMI can also cause inappropriate pacing in patients with rate responsive pacemakers. Rate responsiveness is a feature that allows the pacemaker to increase its rate secondary to perceived physical exertion. Common rate responsive technology uses minute ventilation sensors, which can be triggered by EMI, resulting in inappropriate increases in pacing rate [13, 14] .
In contrast to the ASA Practice Advisory [15] , the HRS/ ASA Consensus Statement suggests that due to the decreased likelihood of EMI related interference seen when surgery is below the umbilicus, the patient should proceed to surgery with no magnet application to the device or reprogramming. However, there should be a magnet available with the magnet function of the device known in case of a change in surgical plan or unexpected EMI. Alternatively, a magnet can be applied if perioperative physicians feel more comfortable with that approach, provided the perioperative team is aware of the magnet function for that particular device. Interestingly, magnets were never developed for perioperative use, although they are now widely considered for shielding of EMI or treatment of CIED emergencies. Magnets were initially used to determine battery life in CIEDs. However, both magnet application and reprogramming are options for eliminating EMI. The choice of reprogramming versus magnet application largely depends on the type of surgery, patient position, accessibility of programmer, and knowledge of magnet function of a particular patient's device. It should be emphasized that a magnet has different effects when applied to a pacemaker or to an ICD. In the majority of pacemakers, magnet application induces an asynchronous mode. Magnet application to an ICD inhibits tachyarrhythmia detection, thus preventing therapy, i.e., delivery of shocks. However it does NOT change the mode of the underlying pacemaker. Therefore, a magnet placed over an ICD will not induce asynchronous mode in the underlying pacemaker. For patients with an ICD who are pacemakerdependent, reprogramming is the preferred option if EMI is a significant concern. For a few ICDs, notably an older model known as the PRIZM series (Boston Scientific-Guidant), the magnet mode can be changed to induce suspension of tachyarrhythmia therapy only after the magnet is applied for 30 s. Tachytherapy will be reactivated when the magnet is reapplied for 30 s. For any device, the magnet response should be confirmed with the CIED team prior to magnet application. While most pacemakers will convert to asynchronous mode when a magnet is applied to the generator, some devices have a programmable magnet function that can prevent conversion to asynchronous mode when a magnet is placed over the generator. For this reason, it is important to consult with the patient's CIED team to determine a particular device's magnetic response.
Electrical Reset
Pacemakers and ICDs are reliable devices that may malfunction [16, 17] . A type of malfunction that is commonly misunderstood is the concept of electrical reset. In the perioperative setting, this is thought to very rarely occur when an energy surge directly contacts the pulse generator, resulting in a major hardware/software failure. The reset mode is unique to each manufacturer and serves as a safety backup in the case of catastrophic failure. The most common cause of electrical reset is therapeutic radiation, not electrocautery or external cardioversion/defibrillation [18] [19] [20] . Neither magnet application nor reprogramming will prevent electrical reset. The best prevention of electrical reset is to direct energy away from the pulse generator ([15 cm) and to place the dispersive electrode (''Bovie pad'') in proper position to prevent current flow across the generator. Although current recommendations strongly recommend a tailored approach to perioperative CIED management based on the patient's CIED history, type of surgery, and medical co-morbidities, it can be helpful to have a general idea of the management of CIEDs when patients present for surgery. There are numerous sources available that suggest approaches to perioperative management [21] [22] [23] ; a sample algorithm is shown in Fig. 1 .
For patients who have had a CIED placed within the prior six weeks, care must be taken during invasive procedures such as central line insertion and pulmonary artery catheter placement, as the risk for dislodgment is increased until the pacing/ICD leads become solidly fixated within the endocardium. Additionally, patients with a cardiac resynchronization device (also called a biventricular pacemaker or biventricular ICD) have a coronary sinus lead that can be more easily dislodged when compared to a chamber lead since there is no mechanism of lead fixation in the coronary sinus.
Emergency Protocol
Patients with CIEDs may present for urgent/emergent surgery, leaving little or no time for device interrogation or CIED team consultation. In such instances, identification of the device is important. If the patient does not know the type of device (pacemaker, ICD, biventricular pacemaker, biventricular ICD, etc.), chest radiography can be used to help identify the device.
An electrocardiogram or rhythm strip should be examined for pacing spikes. If pacing spikes are noted before most or all of either the P wave or the QRS complexes, then the patient should be treated as if he/she is pacemakerdependent. All pacemaker-dependent patients and patients with ICDs should have transcutaneous pacing and defibrillator pads placed during emergency cases. A magnet should always be available and its use is recommended in the pacemaker-dependent patient as well as the patient with an ICD. Regardless of the type of device, interrogation of the CIED under the direction of a physician knowledgeable in the function of devices should occur as soon as possible. The emergency protocol is described in the HRS/ASA Expert Consensus Statement.
Postoperative Management of CIEDs
Postoperative management of CIEDs should be addressed in the preoperative assessment, but may need modifications based on intraoperative events. As with the preoperative assessment, the plan for perioperative care should be individualized to meet the needs of the patient. The patient's medical history, history of adherence to medical recommendations, type of device and surgical course will help determine the most appropriate postoperative management. Recommendations from the HRS/ASA Expert Consensus Statement suggest that patients receive either a telephonic or clinical evaluation of their device within 30 days of surgery, except in a few circumstances. Devices will require interrogation in the immediate postoperative period in only a few instances. First, if any programming changes were made preoperatively, then the device should be reprogrammed to its preoperative settings prior to discharge from a telemetry unit. If there is a concern for nonadherence to recommended follow-up within 30 days, then the device should be interrogated in the immediate postoperative period. Lastly, if there are unusual circumstances regarding the surgery, such as large blood loss/fluid administration, intraoperative defibrillation/cardioversion, or concern for direct damage to the CIED, then the device should be interrogated in the immediate postoperative period.
Conclusions
Patients with CIEDs are presenting for elective surgery in ever increasing numbers. Anesthesiologists will increasingly be called upon to assist in the development of institution-specific strategies based on local resources to efficiently manage patients with CIEDs who present for surgery. A basic understanding of CIEDs combined with continuing education about the perioperative management of these devices will assist anesthesiologists in the important task of caring for patients with CIEDs.
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